about
Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies.Adoptive immunotherapy induces CNS dendritic cell recruitment and antigen presentation during clearance of a persistent viral infectionImmunotherapeutic relief from persistent infections and amyloid disorders.A novel virus carrier state to evaluate immunotherapeutic regimens: regulatory T cells modulate the pathogenicity of antiviral memory cellsPersistent viral infection elevates central nervous system MHC class I through chronic production of interferons.Mapping and restriction of a dominant viral CD4+ T cell core epitope by both MHC class I and MHC class II.
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Immunocytotherapy.
@ast
Immunocytotherapy.
@en
Immunocytotherapy.
@nl
type
label
Immunocytotherapy.
@ast
Immunocytotherapy.
@en
Immunocytotherapy.
@nl
prefLabel
Immunocytotherapy.
@ast
Immunocytotherapy.
@en
Immunocytotherapy.
@nl
P1476
Immunocytotherapy.
@en
P2093
P577
2002-01-01T00:00:00Z